FeaturesSignalPricingFounders
Log inGet started free
FF

Francine Fang

OtherActive

Managing Partner at 3E Bioventures Capital

Beijing, ChinaFounded 20213ebiovc.com/index.php?m=content&c=index&a=show&catid=9&id=3#content
18
Investments
0
Exits
—
AUM
0.0%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Francine Fang.

Get started free

Investment Thesis & Strategy

Francine Fang, as Managing Partner at 3E Bioventures Capital, invests in various stages of biotech companies, seeking innovative solutions within the biotech sector.

Investment Activity

Deals per year over the last 6 years

1
2013
1
2014
1
2015
5
2016
1
2017
1
2018

Portfolio Companies

Selected investments from their portfolio of 18 companies

D
Doctor Shaoyang
Healthcare · Seed, 0
Active
L
Ligatech Bioscience
Biotech · Seed, 0
Active
C
Cullgen
Biotech · Series B, 2018
Active
S
Subtle Medical
Healthcare · Series A, 2017
Active
C
C4 Therapeutics
Biotech · Series C+, 2016
Active
C
Cytek Biosciences
Biotech · Series C+, 2016
Active
E
EpimAb Biotherapeutics
Biotech · Series B, 2016
Active
O
OncoImmune
Biotech · Series B, 2016
Active
R
Refuge Biotechnologies
Biotech · Seed, 2016
Active
E
Eucure Biopharma
Biotech · Series B, 2015
Active
B
Biocytogen
Biotech · Growth, 2014
Active
C
Cardea Bio
Biotech · Series B, 2013
Active

Frequently Asked Questions

Francine Fang focuses on Seed stage investments.

Related Investors

China Equity

Beijing, China · 63 deals

China Renaissance

Beijing, China · 29 deals

China Development Bank

Beijing, China · 15 deals

China CITIC Bank

Beijing, China · 10 deals

China Minsheng Bank

Beijing, China · 10 deals

China Securities

Beijing, China · 8 deals